Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -17.50%22.96M | -8.60%20.6M | -16.68%23.96M | -17.04%101.88M | -28.24%22.75M | 27.83M | 22.54M | 28.76M | 8.65%122.8M | 5.53%31.71M |
| Cost of revenue | -6.63%15.63M | 7.60%15.02M | -1.59%16.69M | -13.39%63.85M | -12.14%16.27M | 16.74M | 13.96M | 16.96M | 20.96%73.72M | 9.91%18.52M |
| Gross profit | -33.92%7.33M | -34.93%5.59M | -38.38%7.27M | -22.51%38.03M | -50.85%6.48M | 11.09M | 8.58M | 11.8M | -5.76%49.08M | -0.06%13.19M |
| Operating expense | -25.14%7.9M | -6.79%6.75M | -16.67%7.74M | -9.35%34.97M | -25.11%7.81M | 10.56M | 7.24M | 9.29M | -13.20%38.58M | 0.03%10.43M |
| Selling and administrative expenses | -25.14%7.9M | -6.79%6.75M | -16.67%7.74M | -9.35%34.97M | -25.11%7.81M | --10.56M | --7.24M | --9.29M | 5.16%38.58M | 23.93%10.43M |
| -Selling and marketing expense | -30.38%5.65M | -10.94%4.25M | -11.75%5.2M | -12.14%24.14M | -17.06%5.36M | --8.11M | --4.77M | --5.9M | -19.03%27.47M | -16.88%6.46M |
| -General and administrative expense | -7.83%2.26M | 1.21%2.5M | -25.21%2.54M | -2.47%10.84M | -38.25%2.45M | --2.45M | --2.47M | --3.39M | 302.95%11.11M | 523.78%3.96M |
| Operating profit | -209.07%-577K | -187.01%-1.17M | -118.68%-469K | -70.89%3.06M | -147.96%-1.33M | 529K | 1.34M | 2.51M | 37.52%10.49M | -0.40%2.76M |
| Net non-operating interest income (expenses) | -44.12%-147K | 0.00%-164K | 19.62%-127K | 40.96%-537.02K | 55.69%-113K | -102K | -164K | -158K | 39.44%-909.58K | 33.42%-255K |
| Non-operating interest expense | 44.12%147K | 0.00%164K | -19.62%127K | -40.96%537.02K | -55.69%113K | --102K | --164K | --158K | -27.93%909.58K | -20.06%255K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -900K | |||||||||
| Other non-operating income (expenses) | 93.09%-52K | -277.50%-302K | -74.61%114K | -291.65%-46.71K | 145.84%336K | -752K | -80K | 449K | -81.11%24.37K | -36,550.00%-733K |
| Income before tax | -138.77%-776K | -248.91%-1.63M | -117.20%-482K | -74.28%2.47M | -162.08%-1.1M | -325K | 1.1M | 2.8M | 30.90%9.61M | 19.05%1.78M |
| Income tax | -120.73%-57K | -139.86%-177K | -93.23%59K | -28.97%2.02M | -36.93%427K | 275K | 444K | 871K | 47.78%2.84M | 37.60%677K |
| Net income | -19.83%-719K | -323.16%-1.46M | -128.02%-541K | -93.29%454.18K | -239.25%-1.53M | -600K | 652K | 1.93M | 24.91%6.77M | 9.91%1.1M |
| Net income continuous operations | -19.83%-719K | -323.16%-1.46M | -128.02%-541K | -93.29%454.18K | -239.25%-1.53M | ---600K | --652K | --1.93M | 24.91%6.77M | 9.91%1.1M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -19.83%-719K | -323.16%-1.46M | -128.02%-541K | -93.29%454.18K | -239.25%-1.53M | -600K | 652K | 1.93M | 24.91%6.77M | 9.91%1.1M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.83%-719K | -323.16%-1.46M | -128.02%-541K | -93.29%454.18K | -239.25%-1.53M | -600K | 652K | 1.93M | 24.91%6.77M | 9.91%1.1M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.05%-0.0025 | -321.74%-0.0051 | -122.35%-0.0019 | -92.97%0.0017 | -240.27%-0.0055 | -0.0021 | 0.0023 | 0.0085 | 24.91%0.0242 | 9.89%0.0039 |
| Diluted earnings per share | -19.05%-0.0025 | -321.74%-0.0051 | -122.35%-0.0019 | -92.97%0.0017 | -240.27%-0.0055 | -0.0021 | 0.0023 | 0.0085 | 24.91%0.0242 | 9.89%0.0039 |
| Dividend per share | 0 | 0 | 0 | 0.015 | 0 | 0 | 0.015 | |||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.